TEVA

17.26

2.86% 0.48

Dopo l'orario di chiusura: 17.34 0.08 +0.46%

Teva Pharmaceutical Industries Ltd Adr (TEVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TEVA Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$16.78

Aprire:

$16.87

Volume 24 ore:

9.48M

Relative Volume:

0.80

Capitalizzazione di mercato:

$19.79B

Reddito:

$16.54B

Utile/perdita netta:

$-1.64B

Rapporto P/E:

-11.90

EPS:

-1.45

Flusso di cassa netto:

$749.00M

1 W Prestazione:

+1.77%

1M Prestazione:

+6.61%

6M Prestazione:

+3.66%

1 anno Prestazione:

+1.95%

Intervallo 1D:

$16.52

$17.28

Intervallo di 1 settimana:

$16.52

$18.28

Portata 52W:

$12.46

$22.80

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile

Nome

Teva Pharmaceutical Industries Ltd Adr

Settore

Healthcare (1166)

Industria

Drug Manufacturers - Specialty & Generic (1)

Telefono

972 (3) 914-8213

Indirizzo

TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV

Dipendente

35,686

Cinguettio

@TevaUSA

Prossima data di guadagno

2025-01-29

Ultimi documenti SEC

TEVA's Discussions on Twitter

Confronta TEVA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TEVA Teva Pharmaceutical Industries Ltd Adr	17.26	20.31B	16.54B	-1.64B	749.00M	-1.45
HLN Haleon Plc Adr	11.41	50.54B	14.35B	1.85B	0	0.4023
ZTS Zoetis Inc	169.42	74.02B	9.29B	2.52B	2.28B	5.57
RDHL Redhill Biopharma Ltd Adr	1.80	4.22M	35.75M	11.57M	-26.25M	-3.8069
TAK Takeda Pharmaceutical Co Adr	15.08	45.82B	30.08B	710.16M	4.45B	0.2182

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-05-28	Iniziato	Truist	Buy
2025-05-12	Aggiornamento	JP Morgan	Neutral → Overweight
2024-07-10	Aggiornamento	Argus	Hold → Buy
2024-03-08	Aggiornamento	JP Morgan	Underweight → Neutral
2024-02-12	Aggiornamento	Piper Sandler	Neutral → Overweight
2024-01-23	Aggiornamento	Jefferies	Hold → Buy
2024-01-03	Aggiornamento	Piper Sandler	Underweight → Neutral
2023-12-18	Iniziato	HSBC Securities	Buy
2023-11-27	Aggiornamento	UBS	Neutral → Buy
2023-07-06	Aggiornamento	UBS	Sell → Neutral
2023-05-25	Iniziato	Morgan Stanley	Equal-Weight
2023-05-18	Aggiornamento	Evercore ISI	In-line → Outperform
2023-01-19	Downgrade	Jefferies	Buy → Hold
2022-11-14	Downgrade	JP Morgan	Neutral → Underweight
2022-11-04	Downgrade	UBS	Neutral → Sell
2022-10-21	Ripresa	Jefferies	Buy
2022-08-05	Aggiornamento	BofA Securities	Neutral → Buy
2022-06-14	Ripresa	UBS	Neutral
2022-05-17	Aggiornamento	BofA Securities	Underperform → Neutral
2022-05-04	Downgrade	Piper Sandler	Neutral → Underweight
2022-04-05	Aggiornamento	Barclays	Equal Weight → Overweight
2022-03-25	Aggiornamento	Bernstein	Mkt Perform → Outperform
2022-01-27	Downgrade	Argus	Buy → Hold
2021-10-28	Downgrade	Raymond James	Outperform → Mkt Perform
2021-05-04	Downgrade	UBS	Buy → Neutral
2021-04-07	Ripresa	RBC Capital Mkts	Sector Perform
2020-11-25	Iniziato	Oppenheimer	Perform
2020-08-06	Aggiornamento	Barclays	Underweight → Equal Weight
2020-07-27	Ripresa	Goldman	Neutral
2020-06-01	Aggiornamento	SunTrust	Hold → Buy
2020-04-24	Ripresa	Citigroup	Neutral
2020-04-06	Aggiornamento	UBS	Neutral → Buy
2020-02-24	Downgrade	Edward Jones	Hold → Sell
2019-11-12	Aggiornamento	JP Morgan	Underweight → Neutral
2019-10-17	Aggiornamento	Gabelli & Co	Hold → Buy
2019-08-07	Downgrade	Evercore ISI	Outperform → In-line
2019-07-19	Iniziato	Wolfe Research	Peer Perform
2019-07-15	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2019-07-10	Ripresa	Credit Suisse	Neutral
2019-07-05	Aggiornamento	Argus	Hold → Buy
2019-06-11	Iniziato	Barclays	Underweight
2019-06-03	Aggiornamento	Oppenheimer	Perform → Outperform
2019-05-30	Downgrade	BofA/Merrill	Buy → Underperform
2019-05-28	Downgrade	UBS	Buy → Neutral
2019-03-20	Iniziato	SunTrust	Hold
2019-03-07	Ripresa	UBS	Buy

Mostra tutto

Teva Pharmaceutical Industries Ltd Adr Borsa (TEVA) Ultime notizie

May 30, 2025

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025 - GlobeNewswire Inc.

May 30, 2025

May 29, 2025

Teva: New Long-Term Targets and Sold Pipeline Reaffirm Our Favorable Outlook; Shares Undervalued - Morningstar

May 29, 2025

May 28, 2025

TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate - Yahoo Finance

May 28, 2025

May 20, 2025

Restart of Student Loan Repayments Could Squeeze Consumer Spending and Slow Economic Growth - iHeart

May 20, 2025

May 19, 2025

Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - GlobeNewswire Inc.

May 19, 2025

May 12, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

May 12, 2025

May 07, 2025

Teva Earnings: Innovation Propels Sales and Generics Show Stability in Solid Start to the Year - Morningstar

May 07, 2025

May 05, 2025

Teva and Alvotech stocks jump on FDA approval of SELARSDI - Investing.com

May 05, 2025

Teva and Alvotech stocks jump on FDA approval of SELARSDI By Investing.com - Investing.com Canada

May 05, 2025

Apr 30, 2025

There Are Mixed Signals on the Chart for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - uspostnews.com

Apr 30, 2025

Digi Power X Inc (DGXX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com

Apr 30, 2025

Apr 29, 2025

Market Analysts see Norwegian Cruise Line Holdings Ltd [NCLH] gaining to $21. Time to buy? - dbtnews.com

Apr 29, 2025

PG&E Corp [PCG] Revenue clocked in at $24.54 billion, down -14.37% YTD: What’s Next? - dbtnews.com

Apr 29, 2025

Greenwave Technology Solutions Inc [GWAV] Is Currently 12.13 above its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com

Apr 29, 2025